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Introduction
Plasmapheresis (PF) is an extracorporeal blood purification
technique designed to remove large molecular weight
particles from plasma. There is growing evidence on the
benefit of this technique in different clinical diseases that
would deserve intensive care.
Objectives
To report our experience in PF performed with CRRT
monitors (Prismaflex® System, Gambro) with a filter
membrane, which allows the removal of particles up to
3x106 Da. To analyze the characteristics of our patients,
the technique and its complications.
Methods
Assessment of all the PF sessions carried out in a 12-bed
medical ICU in Spain (October 2013-February 2015).
Hemodynamic data were measured before and during
each session. Haematological and biochemical parameters
were analyzed before, at the end of each session, and
thereafter following a recovery period (13.9 ± 0.5 hours).
Statistical paired analysis was made by Wilcoxon test.
Results
A total of 49 sessions were performed in 5 patients with
neurological disease. 80% of our patients were female.
Median age: 42 (IQR 35-71) years. Median number of
sessions in each cycle: 4 (range 3-6). Plasma volume
exchange ratio was 1:1. Replacement fluid used was
Hemosol B0 TM (Gambro) with addition of albumin (to
achieve a concentration of 3-4 g/dL) and KCl (4.1 ± 0.3
mmol/L). Session mean duration: 2.9 ± 0.1 hours.
During PF, a decrease (p < 0.05) in systolic BP (124 ± 17
to 113 ± 19 mmHg) and diastolic BP (68 ± 11 to 62 ± 10
mmHg) was observed. Nevertheless, norepinephrine up to
0.27 mcg/kg/min was only necessary in 10% (5/49) of the
sessions. Main significant analytical results in Table 1.
Transient significant leukocytosis with no signs of infec-
tion developed after PF. This was due to an increase in the
neutrophils count (6.4 ± 2.5 to 12.4 ± 5.3 cells 103/µL,p <
0.05); lymphocytes trend to decrease although without
reaching statistical significance (1.9 ± 1.5 to 1.6 ± 1 cells
103/µL,p= 0.09). Although serum Sodium and Chloride
varied significantly with PF, their levels remained within
normal ranges, whereas serum Potassium remained stable
due to replacement fluid concentration administered.
Red blood cell transfusion was accomplished in 8.2%(4/
49), platelets transfusion in 2%(1/49) and fresh-frozen
plasma transfusion in 6%(3/49) of the sessions. A mean
fibrinogen concentrate dose of 1.9 ± 1.2g. was admini-
strated in 59.2%(29/49) of the sessions. Electrolytes distur-
bances were corrected based on medical criteria.
Complications detected were coagulation of extracor-
poreal system(n = 1), catheter thrombosis(n = 1) and
femoral catheter contamination(n = 1) due to indwelling
catheter urinary tract infection. No major bleeding, or
therapy-related deaths were registered.
Conclusions
PF is a safe therapy performed with CRRT monitors by
ICU staff. Hemodynamic, hematological and biochemical
changes occur with no related symptoms whether early
appropriate adjustment is established. Close electrolytes
monitoring for prompt correction is mandatory.
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Table 1 PF. Mean ± SD; Median(IQR).
BEFORE PF Before vs after AFTER PF After vs recovery RECOVERY Before vs recovery
Leukocytes (103 /µL) 9.4 ± 2.3 P < 0.05 14.8 ± 5.4 P < 0.05 10.6 ± 3.3 P < 0.05
Haemoglobin (g/dL) 10.8 ± 1.8 P < 0.05 11.5 ± 2.1 P < 0.05 10.8 ± 1.9 P= 0.21
Platelets(103 /µL) 221.8 ± 85.3 P = 0.49 213.1 ± 86.1 P < 0.05 209.7 ± 89 P < 0.05
Prothrombin Act. (%) 97.7 ± 12.1 P < 0.05 53.2 ± 12.4 P < 0.05 81.5 ± 11 P < 0.05
Fibrinogen (mg/dL) 232.2 ± 107.7 P < 0.05 100.1 ± 57.2 P < 0.05 164.4 ± 58.5 P < 0.05
Magnesium (mg/dL) 2 (1.9-2.2) P < 0.05 1.9 (1.7-2.1) P < 0.05 2 (1.8-2.1) P = 0.16
Phosphorus (mg/dL) 3.2 (2.6-3.4) P < 0.05 2.7 (2.4-2.9) P < 0.05 3.1 (2.6 - 3.4) P = 0.42
Ionized Calcium (mmol/L) 1.15(1.1-1.17) P < 0.05 1.1(1.07-1.13) P < 0.05 1.14(1.1-1.16) P = 0.68
Albumin (g/dL) 3.2 ± 0.5 P < 0.05 3.8 ± 0.4 P < 0.05 3.3 ± 0.6 P= 0.13
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